Product

5-Fluorouracil + Calcium Folinate + Irinotecan

Aliases

5-fluorouracil, Calcium folinate and Irinotecan, FOLFIRI

1 clinical trial

1 indication

Indication

Neuroendocrine Carcinoma

Clinical trial

A Phase 3, Randomized, Open-label, Multi-center Study to Evaluate the Efficacy and Safety of Surufatinib Plus Toripalimab Versus FOLFIRI as a Secondline Treatment in Patients With Advanced Neuroendocrine Carcinoma

Status: Recruiting, Estimated PCD: 2025-05-31